Exodus Technology

Nanoparticle-based, Non-drug Solution for Targeted, Permanent Chronic Pain Relief

Active Pre-Seed Startup Giv'at Shmuel Founded 2025-03

Nano Painkiller offers Focus Pain Ablation (FPA) technology as a groundbreaking, non-drug solution for targeted, permanent chronic pain relief. This innovation addresses the massive global health and economic burden of chronic pain, which affects approximately 20% of the adult Western population and fuels a global drug market valued at $78.41 billion in 202…

SectorHealth Tech & Life Sciences
StagePre-Seed
Total raised$150K
Employees3
Founded2025-03
HQGiv'at Shmuel
Patents1
Confidence80
Sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technology
Materials & SubstancesNanomaterialsBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatientsProviders